lidocaine 2% — Class II drug recall D-0004-2024
Terminated recall by Central Admixture Pharmacy Services Inc, reported 2023-10-11, distributed nationwide. Lack of assurance of sterility:
| Recall number | D-0004-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Central Admixture Pharmacy Services Inc, San Diego, CA, United States |
| Recall initiated | 2023-09-21 |
| Classified | 2023-10-04 |
| Reported by FDA | 2023-10-11 |
| Terminated | 2025-03-19 |
| Distributed | Nationwide (US) |
| Quantity | 1,992 |
| Reason classes | sterility |
| NDC | 71286-6006-01 |
| Lot numbers | 17-275788, 17-275872, 17-275922, 17-275972, 17-275973 |
| Expiration dates | 2023-10-10, 2023-10-11, 2023-10-12, 2023-10-15 |
Product
lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1
Reason for recall
Lack of assurance of sterility:
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0004-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.